XML 1072 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Benefit and Stock Plans (Tables)
12 Months Ended
Nov. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Based Compensation Expense
The following table presents our stock-based compensation expense (in thousands):
 
Years Ended November 30,
 
2018
 
2017
 
2016
Stock options
$
917

 
$
2,592

 
$
7,076

Restricted stock
4,600

 
4,177

 
2,630

PSUs
8,790

 
6,439

 
5,343

Director awards
1,554

 
1,425

 
1,801

Total
$
15,861

 
$
14,633

 
$
16,850

Stock option transactions
Stock option transactions are summarized as follows:
 
Years Ended November 30,
 
2018
 
2017
 
2016
 
Options
 
Weighted
Average
Exercise
Price
 
Options
 
Weighted
Average
Exercise
Price
 
Options
 
Weighted
Average
Exercise
Price
Options outstanding at beginning of year
9,265,240

 
$
17.64

 
12,731,545

 
$
18.95

 
12,635,644

 
$
19.39

Granted

 

 

 

 
1,012,686

 
16.21

Exercised
(1,195,926
)
 
16.73

 
(1,650,360
)
 
16.01

 
(551,898
)
 
13.95

Cancelled
(831,770
)
 
33.05

 
(1,815,945
)
 
28.31

 
(364,887
)
 
34.07

Options outstanding at end of year
7,237,544

 
$
16.02

 
9,265,240

 
$
17.64

 
12,731,545

 
$
18.95

Options exercisable at end of year
6,948,670

 
$
16.01

 
8,307,632

 
$
17.86

 
10,506,810

 
$
19.70

Options available for grant at end of year
6,418,197

 
 
 
7,495,792

 
 
 
7,034,523

 
 
Stock options outstanding and stock options exercisable
Stock options outstanding and stock options exercisable at November 30, 2018 are summarized as follows:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Price
 
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
 
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
 
$  6.32 to $11.05
 
1,201,167

 
$
6.36

 
2.9

 
1,201,167

 
$
6.36

 
 
$11.06 to $14.62
 
2,048,758

 
12.99

 
4.0

 
2,048,758

 
12.99

 
 
$14.63 to $16.20
 
1,906,964

 
15.14

 
4.1

 
1,906,964

 
15.14

 
 
$16.21 to $28.10
 
1,300,596

 
16.35

 
6.8

 
1,011,722

 
16.39

 
 
$28.11 to $45.68
 
780,059

 
40.46

 
0.8

 
780,059

 
40.46

 
 
$  6.32 to $45.68
 
7,237,544

 
$
16.02

 
4.0

 
6,948,670

 
$
16.01

 
3.8

Assumptions of Black-Scholes option-pricing model
The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
 
Years Ended November 30,
 
2018
 
2017
 
2016
Risk-free interest rate

 

 
1.3
%
Expected volatility factor

 

 
41.3
%
Expected dividend yield

 

 
.6
%
Expected term

 

 
5 years

Restricted stock transactions
Restricted stock transactions are summarized as follows:
 
Years Ended November 30,
 
2018
 
2017
 
2016
 
Shares
 
Weighted
Average
per Share
Grant Date
Fair Value
 
Shares
 
Weighted
Average
per Share
Grant Date
Fair Value
 
Shares
 
Weighted
Average
per Share
Grant Date
Fair Value
Outstanding at beginning of year
503,926

 
$
21.69

 
604,619

 
$
16.24

 
416,977

 
$
15.88

Granted
303,030

 
23.05

 
321,835

 
24.49

 
453,703

 
15.73

Vested
(221,951
)
 
19.79

 
(364,670
)
 
16.09

 
(252,854
)
 
14.78

Cancelled
(29,548
)
 
21.76

 
(57,858
)
 
15.61

 
(13,207
)
 
15.12

Outstanding at end of year
555,457

 
$
23.19

 
503,926

 
$
21.69

 
604,619

 
$
16.24

Schedule of Share Based Payments Performance Shares Activity
PSU transactions are summarized as follows:
 
Years Ended November 30,
 
2018
 
2017
 
2016
 
Shares
 
Weighted
Average
per Share
Grant Date
Fair Value
 
Shares
 
Weighted
Average
per Share
Grant Date
Fair Value
 
Shares
 
Weighted
Average
per Share
Grant Date
Fair Value
Outstanding at beginning of year
925,232

 
$
20.09

 
809,860

 
$
17.19

 
820,209

 
$
15.52

Granted
603,424

 
25.70

 
424,797

 
22.99

 
369,281

 
13.81

Vested
(437,689
)
 
31.28

 
(278,460
)
 
16.67

 
(374,630
)
 
10.21

Cancelled

 

 
(30,965
)
 
14.92

 
(5,000
)
 
16.21

Outstanding at end of year
1,090,967

 
$
18.70

 
925,232

 
$
20.09

 
809,860

 
$
17.19